Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff
marketwatch.com
08.09.2026
Related stories
Portfolio Diversification Is the Simplest Way to Lower Risk. Here's How I Build Mine.
China just launched a $19,170 electric vehicle
LPL Financial Group Managing Director Sells 308 Shares for $110,100
American Tower Sees 2026 Growth Trough Before 5G, AI and 6G Catalysts Lift Demand
AI Agents Create Their Own Monitoring Problem. Datadog and Dynatrace Are Racing to Own It
How Much Does a 61-Year-Old Need Invested to Collect $8,600 a Month for Life?